Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

OWC Pharmaceutical Research Corp Reports Progress in Clinical Trials for Ointment Care for Skin Diseases

OWC Pharmaceutical Research Corp.
Posted on: 29 Nov 18
OWC Pharmaceutical Research Corp Reports Progress in Clinical Trials for Ointment Care for Skin Diseases

PR Newswire

RAMAT GAN, Israel, Nov. 29, 2018

RAMAT GAN, Israel, Nov. 29, 2018 /PRNewswire/ -- OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, reported today that the last healthy volunteer in its first ever safety study of cannabis-based topical ointment, was recently admitted in trial which is being conducted at Sheba Medical Center, Tel Hashomer, Israel. Mr. Mordechai Bignitz, OWC Pharmaceutical CEO commented: " We are extremely pleased with the progress on this trial. Recruiting has now been completed and we expect to complete the trial by the end of December".

Mr. Bignitz added: "We recently had the opportunity to present our innovative research and pipeline progress to investors and potential business partners at the MJBizCon in Las Vegas. We are evaluating a number of potential avenues to accelerate our development as we strongly believe that our innovative dosage forms, delivery platforms and our clinical research can unlock the potential of cannabis-based treatments and improve patients'quality of life".  

About OWC Pharmaceutical Research Corp

OWC Pharmaceutical Research Corp., through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., (collectively 'OWC' or the 'Company') conducts medical research and clinical trials to develop cannabis-based pharmaceuticals and treatments for conditions including multiple myeloma, psoriasis, fibromyalgia, PTSD, and migraines.

OWCP is also developing unique and effective delivery systems and dosage forms of medical cannabis. All OWC research is conducted at leading Israeli hospitals and scientific institutions and led by internationally renowned investigators.

Contact: Mordechai Bignitz , Chief Executive Officer - OWC Pharmaceutical research crop,
info@owcpharma.com, Tel: +972-(72)-260-8004

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/owc-pharmaceutical-research-corp-to-report-progress-in-clinical-trials-for-ointment-care-for-skin-diseases-300757541.html

SOURCE OWC Pharmaceutical Research Corp.

PR Newswire
www.prnewswire.com

Last updated on: 29/11/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.